zzweb-панель

Регенеративная Медицина — Александр Жаворонков

http://img.zzweb.ru/img//727131/my lab 2.png


Alex Zhavoronkov, PhD, is the director and a trustee of the Biogerontology Research Foundation, a think tank supporting aging research worldwide and is the founder of the International Aging Research Portfolio (IARP) ссылка, a curated knowledge management system for aging research. He heads the laboratory of regenerative medicine at the Clinical Research Center for Pediatric Hematology, Oncology and Immunology ссылка, and heads NeuroG ссылка, a neuroinformatics project intended to assist the elderly suffering from dementia. Prior to IARP, Alex worked as the director of ATI Technologies (acquired by AMD), GTCBio, Mediox, Colby Pharmaceutical Company and General Nano Optics. He consulted and helped set up many initiatives with a mission to improve senior productivity and extend health span.

Mission:
Accelerate research in aging and regenerative medicine to extend healthy active lifespan

Presentation:
ссылка

Upcoming Books(July 2, 2013):
The Ageless Generation: How Advances in Biomedicine Will Transform the Global Economy
Publisher: Palgrave Macmillan
Language: English
ISBN-10: 0230342205
ISBN-13: 978-0230342200
ссылка
ссылка

As millions of baby boomers become eligible for Social Security and Medicare, government spending on these programs will spiral out of control, creating massive recessions, high unemployment, and possibly the collapse of the dollar. Not only does this place strain on governments, but it places an extraordinary burden on the dwindling number of remaining workers whose taxes must support these programs. Alex Zhavoronkov, an expert in aging and biomedical research, believes that the coming crisis can be avoided by slowing aging— giving tomorrow’s seniors extra years or even decades of healthy, productive life in the workforce. This extreme longevity could provide an unprecedented boost to the global economy if policy makers realize the potential of recent medical breakthroughs. Eventually, even greater medical advances could create a nearly ageless society where death only occurs due to trauma or a few remaining intractable diseases. But can we reach this ageless new world before spending on senior programs collapses the world’s economies?

In this fascinating look at advances in biomedical research, Zhavoronkov provides a detailed view of the progress that has already been made, from repairing tissue damage to growing functional organs from a single cell, and illuminates the possibilities that the scientific and medical community will soon make into realities. The implications of this research will touch every aspect of our lives, from the impact of having multiple generations of families alive at the same time to a longer period of time in which individuals can actively contribute to the workforce—and the resulting impact on the global economy will be immeasurable.

90 days of papers that LOVE to be read and cited :)

Evaluating the impact of recent advances in biomedical sciences and the possible mortality decreases on the future of health care and Social Security in the United States
Alex Zhavoronkov, Nawazish Mirza, Irog Artuhov, Edouard Debonneuil
Pensions 2012 Dec 14. 17, 241 – 251. doi: 10.1057/pm.2012.28
Open Access

Characteristic patterns of microRNA expression in human bladder cancer
Anastasia A. Zabolotneva, Alex Zhavoronkov, Andrew V. Garazha, Sergey A. Roumiantsev and Anton A. Buzdin
Front. Gene. doi: 10.3389/fgene.2012.00310
Open Access

The role of D-GADD45 in oxidative, thermal and genotoxic stress resistance.
Moskalev A, Plyusnina E, Shaposhnikov M, Shilova L, Kazachenok A, Zhavoronkov A.
Cell Cycle. 2012 Oct 24;11(22).
Open Access

Potential therapeutic approaches for modulating expression and accumulation of defective lamin A in laminopathies and age-related diseases.
Zhavoronkov A, Smit-McBride Z, Guinan KJ, Litovchenko M, Moskalev A.
J Mol Med (Berl). 2012 Oct 23.
Open Access

Non-invasive prenatal diagnostics of aneuploidy using next-generation DNA sequencing technologies, and clinical considerations.
Nepomnyashchaya YN, Artemov AV, Roumiantsev SA, Roumyantsev AG, Zhavoronkov A.
Clin Chem Lab Med. 2012 Sep 29;0(0):1-14. doi: 10.1515/cclm-2012-0281.
Please contact me for a reprint.
Сеич
Все очень хорошо написано — только очень не понятно. Я английский с пяти лет учил, а потом забыл. Выучил немецкий, и опять забыл.
ДОБАВИТЬ комментарий, предложение, вопрос...